Cargando…
Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221026/ http://dx.doi.org/10.1186/1471-2334-14-S2-P83 |
| _version_ | 1782342833082990592 |
|---|---|
| author | Chantry, AS Tching-Sin, M Dhiver, C Allegre, T Ruiz, JM Assi, A Botta-Fridlund, D Halfon, P Faucher-Zaegel, O Solas, C |
| author_facet | Chantry, AS Tching-Sin, M Dhiver, C Allegre, T Ruiz, JM Assi, A Botta-Fridlund, D Halfon, P Faucher-Zaegel, O Solas, C |
| author_sort | Chantry, AS |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4221026 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42210262014-11-10 Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment Chantry, AS Tching-Sin, M Dhiver, C Allegre, T Ruiz, JM Assi, A Botta-Fridlund, D Halfon, P Faucher-Zaegel, O Solas, C BMC Infect Dis Poster Presentation BioMed Central 2014-05-23 /pmc/articles/PMC4221026/ http://dx.doi.org/10.1186/1471-2334-14-S2-P83 Text en Copyright © 2014 Chantry et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Chantry, AS Tching-Sin, M Dhiver, C Allegre, T Ruiz, JM Assi, A Botta-Fridlund, D Halfon, P Faucher-Zaegel, O Solas, C Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment |
| title | Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment |
| title_full | Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment |
| title_fullStr | Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment |
| title_full_unstemmed | Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment |
| title_short | Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment |
| title_sort | boceprevir (boc) and telaprevir (tpv) therapeutic drug monitoring in hcv and hiv-hcv infected patients treated with triple therapy ribavirine/peg-interferon/boceprevir or telaprevir: impact of the antiretroviral (arv) treatment |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221026/ http://dx.doi.org/10.1186/1471-2334-14-S2-P83 |
| work_keys_str_mv | AT chantryas boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT tchingsinm boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT dhiverc boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT allegret boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT ruizjm boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT assia boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT bottafridlundd boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT halfonp boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT faucherzaegelo boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment AT solasc boceprevirbocandtelaprevirtpvtherapeuticdrugmonitoringinhcvandhivhcvinfectedpatientstreatedwithtripletherapyribavirinepeginterferonboceprevirortelaprevirimpactoftheantiretroviralarvtreatment |